Neuronetics (STIM) grants 500,000 RSUs to EVP and CFO Naor Nir
Rhea-AI Filing Summary
Naor Nir reported acquisition or exercise transactions in this Form 4 filing.
Neuronetics, Inc. granted its EVP, CFO & Treasurer, Naor Nir, a 500,000-share restricted stock unit (RSU) award of common stock on July 23, 2026. The RSUs vest in four equal installments beginning on July 23, 2027, subject to his continuous employment. Each RSU represents a contingent right to receive one share of Neuronetics common stock, resulting in 500,000 shares reported as directly held after the award.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 500,000 shares
Net Buy
1 txn
Insider
Naor Nir
Role
EVP, CFO & Treasurer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1, F2 | 500,000 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 500,000 shares (Direct)
Footnotes (2)
- F1. Represents a restricted stock unit ("RSU") award that vests in four equal installments beginning on July 23, 2027, in each case subject to the Reporting Person's continuous employment with the Issuer through such date.
- F2. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Key Figures
RSU award size: 500,000 shares
Grant price per share: $0.0000 per share
Vesting installments: 4 installments
+1 more
4 metrics
RSU award size
500,000 shares
Restricted stock unit award of common stock granted on July 23, 2026
Grant price per share
$0.0000 per share
Reported price for the 500,000-share RSU grant
Vesting installments
4 installments
RSUs vest in four equal installments beginning on July 23, 2027
Shares following transaction
500,000 shares
Total Neuronetics common stock reported as directly held after the award
Key Terms
restricted stock unit ("RSU"), contingent right, continuous employment
3 terms
restricted stock unit ("RSU") financial
"Represents a restricted stock unit ("RSU") award that vests in four equal installments"
contingent right financial
"Each RSU represents a contingent right to receive one share of the Issuer's common stock"
continuous employment financial
"in each case subject to the Reporting Person's continuous employment with the Issuer"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What equity award did Neuronetics (STIM) grant to EVP & CFO Naor Nir?
Neuronetics granted Naor Nir a 500,000-share RSU award of common stock. The award was reported at a $0.0000 grant price per share and is structured as time-based restricted stock units, each representing one share of Neuronetics common stock upon vesting.
How do the 500,000 RSUs granted by Neuronetics (STIM) to Naor Nir vest?
The 500,000 RSUs vest in four equal installments starting on July 23, 2027. Each installment is contingent on Naor Nir’s continuous employment with Neuronetics through the applicable vesting date, aligning the award with ongoing service.
What does each RSU in Naor Nir’s Neuronetics (STIM) award represent?
Each RSU represents a contingent right to receive one share of Neuronetics common stock. Upon vesting, the RSUs convert into an equivalent number of shares, subject to the award’s service-based vesting and other applicable conditions described in the grant.
What is Naor Nir’s reported Neuronetics (STIM) common stock position after this Form 4 transaction?
After the reported transaction, Naor Nir is shown as directly holding 500,000 shares of Neuronetics common stock. This figure reflects the RSU award reported in the filing and is presented as his total direct holdings following the grant.
Was Naor Nir’s Neuronetics (STIM) RSU grant made under a Rule 10b5-1 trading plan?
The filing indicates the Rule 10b5-1 checkbox is not affirmed, so this RSU grant is not reported as made under a Rule 10b5-1 trading plan. It is disclosed as a grant or award acquisition of equity.